Ischemic vascular microenvironment

The **ischemic vascular microenvironment** refers to the altered local cellular, molecular, and extracellular matrix context that develops in tissues experiencing insufficient blood supply (ischemia)[1][2][7]. It consists of blood vessel endothelial cells, smooth muscle cells, connective tissue cells (fibroblasts, macrophages), extracellular matrix proteins, and dynamic signals such as cytokines and exosomes[1]. Physiologically, this environment regulates vascular tone, cellular homeostasis, and tissue function. In ischemia, the microenvironment is characterized by hypoxia, acidosis, inflammation, increased vascular permeability, and blood-brain barrier disruption[7][2]. These changes contribute to pathology in diseases like stroke, myocardial infarction, and atherosclerosis by promoting inflammation, tissue remodeling, and abnormal angiogenesis[7][1][3]. While some experimental therapies aim to modify the ischemic vascular microenvironment (for example, by targeting angiogenic pathways or restoring blood-brain barrier function), the term does **not** represent a singular molecular drug target, but rather a complex and multifactorial pathophysiological context[1][2][7]. In summary, "ischemic vascular microenvironment" is not a canonical molecule, receptor, or specific target—rather, it is a context or system involving many cell types and signaling pathways in ischemic tissues.

Other names

Vascular microenvironment in ischemiaischemic tissue microenvironmentmicrovascular ischemic environment